NLM Digital Collections

Search

Start Over Subjects United States. Department of Health and Human Services. ✖Remove constraint Subjects: United States. Department of Health and Human Services. Copyright Public domain ✖Remove constraint Copyright: Public domain

191. Personal firearms: programs that promote safe storage and research on their effectiveness : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 2017
Subject(s):
Firearms
Patient Education as Topic
Safety
Wounds, Gunshot -- epidemiology
Wounds, Gunshot -- mortality
Wounds, Gunshot -- prevention & control
Adolescent
Child
Community Networks
Consumer Product Safety
Counseling
Forecasting
Suicide -- prevention & control
Suicide -- statistics & numerical data
Suicide -- trends
Humans
United States
United States. Department of Health and Human Services.

192. Human trafficking: investigations in Indian country or involving Native Americans and actions needed to better report on victims served : testimony before the Committee on Indian Affairs, U.S. Senate

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 27, 2017
Subject(s):
Human Trafficking -- prevention & control
Human Trafficking -- statistics & numerical data
Indians, North American
Data Collection
Federal Government
Human Trafficking -- legislation & jurisprudence
Law Enforcement
Humans
United States
United States. Department of Health and Human Services.
United States. Department of Homeland Security.
United States. Department of Justice.
United States. Department of the Interior.

193. Newborn health: federal action needed to address neonatal abstinence syndrome : report to Congressional addressees

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 2017
Subject(s):
Neonatal Abstinence Syndrome -- economics
Neonatal Abstinence Syndrome -- therapy
Infant, Newborn
Insurance Coverage -- economics
Medicaid -- economics
Mothers
Neonatal Abstinence Syndrome -- drug therapy
Opioid-Related Disorders
Patient Education as Topic
Pregnancy
Prenatal Care
Social Stigma
Substance-Related Disorders -- therapy
Humans
United States
United States. Department of Health and Human Services.

194. Biodefense: federal efforts to develop biological threat awareness : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, October 2017
Subject(s):
Bioterrorism -- prevention & control
Civil Defense
Awareness
Biological Warfare
Data Collection
Information Dissemination
Public Health
Research
Humans
United States
United States. Department of Agriculture.
United States. Department of Defense.
United States. Department of Health and Human Services.
United States. Department of Homeland Security.
United States. Environmental Protection Agency.

195. Part D plans generally include drugs commonly used by dual eligibles: 2017

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2017
Subject(s):
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Insurance Coverage
Medicare Part D -- statistics & numerical data
Drug Utilization
Medicare Part D -- economics
Humans
United States
United States. Department of Health and Human Services.
United States.

196. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Outcome Assessment (Health Care)
Community-Institutional Relations
Buprenorphine -- therapeutic use
Inservice Training
Insurance Coverage
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Prescription Drug Diversion -- prevention & control
Humans
United States
United States. Department of Health and Human Services.

197. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Fraud -- prevention & control
Health Insurance Exchanges
Medicaid
Medicare
Risk Assessment
Risk Management
Fraud -- economics
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
State Children's Health Insurance Program (U.S.)

198. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022
Subject(s):
Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services.

199. Pathological complete response in neoadjuvant treatment of high-risk early-stage breast cancer: use as an endpoint to support accelerated approval

Publication:
[Silver Spring, MD] : United States Food and Drug Administration, Oncology Center of Excellence, July 2020
Subject(s):
Breast Neoplasms
Clinical Trials as Topic
Neoadjuvant Therapy
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

200. Enforcement policy for viral transport media during the Coronavirus disease 2019 (COVID-19) public health emergency: guidance for commercial manufacturers, clinical laboratories, and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality, July 2020
Subject(s):
Culture Media
Specimen Handling
Transportation
Virus Diseases
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.